Artificial Intelligence

Backed by Pfizer Ventures, Enodia Therapeutics' novel AI platform aims to stop diseases by degrading proteins at their source, a major shift in drug discovery.

The merger creates a data and AI powerhouse focused on the Snowflake ecosystem, aiming to help enterprises scale artificial intelligence responsibly.

Paris-based Enodia Therapeutics lands €20.7M to advance its AI platform that degrades disease-causing proteins at the point of synthesis, targeting new cures.

A new campaign says indecision is the biggest business risk. Aily Labs' AI platform promises to end analysis paralysis and force confident, fast action.

The strategic merger creates a new powerhouse in financial data, aiming to challenge giants with a new AI-driven platform, Vanda Analytics.

Record AI mega-deals redefine healthcare innovation, yet a broader market contraction creates a new divide for startups and traditional medical sectors.

With a new CRO from the AI security world, Tiugo Technologies signals an aggressive push to integrate AI across its developer tool portfolio.

One Washington Financial and Papilio Collective are launching a new model to embed expert support into fintechs, aiming to close the innovation gap for credit unions.

Voyager Technologies extends its NASA HUNCH contract, a strategic move to cultivate the next generation of talent for its future Starlab space station.

Global consulting giant Andersen partners with niche firm Scimitar to tackle pharma's biggest challenges, signaling a new model for expertise at scale.

Snowflake's move to buy AI observability firm Observe challenges market incumbents by merging big data analytics with AI-powered troubleshooting.

A new partnership introduces Utilix, an intelligent software aiming to transform static displays into dynamic, data-driven experiences for retail and beyond.

The investment giant's new podcast season tackles the energy trilemma, exploring AI's power thirst, the return of nuclear, and fossil fuel's role.

A new partnership arms independent cancer clinics with advanced AI and data analytics, aiming to improve patient care and ensure their survival.

A new class of painkillers promises the power of opioids with a far lower risk of addiction. Tris Pharma's cebranopadol could reshape pain management.

NeuroSense adds world-renowned expert Prof. Steven Arnold to its board, a major vote of confidence in its multi-target Alzheimer's drug, PrimeC.

As fraud losses top $43B, Vonage’s network-powered Identity Insights API wins a key award for redefining security and trust in the digital economy.

As the AI arms race heats up, Lambda brings in veteran operator Leonard Speiser to lead its $1.5B+ expansion and build the future of AI supercomputing.

The deal integrates specialized AI and therapist-led platforms to boost mental health access for remote communities and spearhead global expansion.

The hospitality tech giant is leveraging its platform with a new AI assistant for retailers, aiming to automate inventory, boost margins, and challenge market leaders.